Dr. Michael Libman on CTV News.

Pharmaceutical company Medicago is based in Quebec city and uses vaccine technology that involves plants. The company will start a phase 3 clinical trial with its COVID-19 vaccine candidate. Dr. Michael Libman, director of the MUHC Vaccine Study Centre and heads the Montreal part of the trial, was interviewed by CTV News and disccuss why it’s exciting on multiple levels.

At least it’s a company with a presence here, with some manufacturing capability here and we would not have to beg other jurisdictions to please let us have some vaccine Dr. Michael Libman

 Watch the interview on CTV News here.